Illumina Inc

Industry:	Pharmaceuticals, Biotechnology
Ranking:	Russell 3000
Revenues:	$366.8 Million
Employees:	596

Description

Illumina, Inc. develops, manufactures and markets integrated systems for the analysis of genetic variation and biological function. Using its technologies, the Company provides a line of products and services that serve the sequencing, genotyping and gene expression markets. The Company’s customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations and biotechnology companies. Its tools provide researchers with the capability to perform genetic tests needed to extract medical information from advances in genomics and proteomics. On January 26, 2007, the Company completed the acquisition of Solexa, Inc. (Solexa). Solexa develops and commercializes genetic analysis technologies used to perform a range of analyses, including whole genome resequencing, gene expression analysis and small ribonucleic acid (RNA) analysis.
(Source: 10-K)

Products & Services

large-scale analysis, next-generation tools, next-generation life-science tools, genetic research tools, genotyping, genomics

Find More Jobs

Job Openings

Receiving Supervisor San Diego , CA

Director of Regulatory Affairs San Diego , CA

Regional Account Manager - Baltimore Washington , DC

Regional Account Manager - North Carolina Raleigh-Durham , NC

Field Service Engineer 2 Detroit , MI

View More Statistics

Site Statistics

Monthly Unique Visitors:	7,820
Site Rank:	199,632
Trust Rating:	Neutral
Stats by

News Archive

Illumina Announces Personal Genome Sequencing Service. Genomics & Genetics Weekly; 7/3/2009 Illumina, Inc. (NASDAQ:ILMN) today unveiled a service program...The Personal Genome Sequencing Service is performed in Illumina's recently certified CLIA laboratory utilizing Illumina's industry leading Genome Analyzer technology. The... ...more

Illumina Announces Roadmap to Five Million Variants for Next-Generation Whole-Genome Genotyping. Biotech Week; 11/4/2009 ...American Society of Human Genetics, Illumina, Inc. (NASDAQ:ILMN) announced its...sample. As part of this announcement, Illumina outlined an ongoing collaboration with...markers on diseases and traits (see also Illumina, Inc.). "We are at a critical point... ...more

Illumina Announces Fully Integrated High-Performance Computing for Sequencing Customers. Biotech Week; 10/21/2009 ...At the BioIT World Europe Conference, Illumina, Inc. (NASDAQ:ILMN) announced the...sequencing platform. Bringing together Illumina's powerful sequencing software with...decentralized analysis servers (see also Illumina, Inc.). "Illumina and our IT partners... ...more